Company news
Monopar Therapeutics Inc. news in 2022
Monopar Therapeutics Inc.'s news releases, calls and decks from 2022, newest first.
Monopar Announces Promising MNPR-202 Data from Ongoing National University of Singapore Collaboration
December 11, 2022
Monopar Announces Encouraging Clinical Data from Ongoing Camsirubicin Phase 1b Trial
November 15, 2022
Monopar Therapeutics Reports Third Quarter 2022 Financial Results and Recent Program Developments
November 9, 2022
Monopar Announces Timeline of Upcoming Data Events for Validive, Camsirubicin, and MNPR-202
October 26, 2022
Monopar Announces Presentation Selected for 2022 American Society of Hematology (ASH) 64th Annual Meeting
October 18, 2022
Monopar Announces Presentation Selected for 2022 Connective Tissue Oncology Society (CTOS) Annual Meeting
October 11, 2022
Monopar Announces Completion of Phase 2b Enrollment and Commencement of Phase 3 Enrollment in its VOICE Trial for Severe Oral Mucositis
October 4, 2022
Monopar to Present at Roth Inaugural Healthcare Opportunities Conference
September 27, 2022
Monopar Therapeutics Reports Second Quarter 2022 Financial Results and Recent Program Developments
August 10, 2022
Monopar Therapeutics Reports First Quarter 2022 Financial Results and Recent Program Developments
May 11, 2022
Monopar Therapeutics Reports Fourth Quarter and Full-Year 2021 Financial Results and Recent Program Developments
March 23, 2022
Monopar to Present at the 34th Annual Roth Conference and Maxim’s 2022 Virtual Growth Conference
March 7, 2022
Monopar Announces Clinical and Preclinical Program Updates
February 14, 2022
Monopar to Present at the H.C. Wainwright BioConnect Conference
January 6, 2022